Financials

Discussions Technicals Seasonals

4132 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to GOLDEN BIOTECHNOLOGY CORP operating, investing, and financing activities

4132 free cash flow for H2 24 is -128.43 M TWD. For 2024, 4132 free cash flow was -263.83 M TWD and operating cash flow was -262.89 M TWD.

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: TWD

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—